Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Diasoft reported for 3 months of fiscal year 2024

8/19/24 DIAS

MD Medical entered Lipetsk

8/19/24 MDMG

Board of Directors of Avangard Bank recommended dividends

8/16/24 AVAN

Slavneft reported for 6 months of 2024 by IFRS

8/16/24 SLAV

HeadHunter may pay dividends by the end of 2024

8/16/24 HEAD

Board of Directors of TNS power Rostov-on-Don recommended dividends

8/16/24 RTSB

Board of Directors of TNS energy Voronezh recommended dividends

8/16/24 VRSB

Inter RAO acquired NPO Elsib

8/16/24 IRAO

Yandex began to develop an analog of the Miro platform

8/16/24 YDEX

Detsky Mir will continue to trade through October 14

8/16/24 DSKY